These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7036371)

  • 41. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
    Utkin VV
    Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901
    [No Abstract]   [Full Text] [Related]  

  • 43. [A short course of chemotherapy in newly diagnosed and retreatment of smear-positive pulmonary tuberculosis in a rural area].
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug; 12(4):220-2, 254-5. PubMed ID: 2636947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis.
    Wolde K; Lema E; Roscigno G; Abdi A
    Ethiop Med J; 1992 Apr; 30(2):63-8. PubMed ID: 1345030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modern treatment of tuberculosis.
    Dutt AK; Stead WW
    Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
    [No Abstract]   [Full Text] [Related]  

  • 47. [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].
    Eule H; Beck H; Evers H; Fischer P; Kwiatkowski H; Merkel S; Reech R; Sieler R; Thomas E; Weinecke W
    Z Erkr Atmungsorgane; 1986; 167(1-2):29-41. PubMed ID: 3532585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapeutic modalities in pulmonary tuberculosis].
    Léophonte P; Didier A; Carré P; Pouchelon E; Rouquet RM
    Rev Prat; 1990 Mar; 40(8):719-24. PubMed ID: 2320896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shortest possible acceptable effective chemotherapy in ambulatory patients with pulmonary tuberculosis. Part II. Results during the 24 months after the end of chemotherapy.
    Mehrotra ML; Gautam KD; Chaube CK
    Am Rev Respir Dis; 1984 Jun; 129(6):1016-7. PubMed ID: 6732040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 51. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 52. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb; 59(2):81-9. PubMed ID: 6379258
    [No Abstract]   [Full Text] [Related]  

  • 53. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report.
    Tam CM; Chan SL; Lam CW; Leung CC; Kam KM; Morris JS; Mitchison DA
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1726-33. PubMed ID: 9620898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Scrofuloderma with hypersensitivity to rifampicin and pyrazinamide, treated with a combination therapy including ofloxacin].
    Belghith I; Badri T; Zaiem A; Benmously R; Mokhtar I
    Presse Med; 2012 Apr; 41(4):437-9. PubMed ID: 22000406
    [No Abstract]   [Full Text] [Related]  

  • 55. Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection.
    Cruz AT; Starke JR
    Pediatr Infect Dis J; 2016 Jul; 35(7):811-3. PubMed ID: 27088582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-course tuberculosis therapy--a new combination product.
    Summers RS; Crewe-Brown HH; Glatthaar E; McCutcheon JP
    S Afr Med J; 1986 Jul; 70(2):120. PubMed ID: 3726702
    [No Abstract]   [Full Text] [Related]  

  • 57. Compliance of patients and physicians: experience and lessons from tuberculosis-II.
    Fox W
    Br Med J (Clin Res Ed); 1983 Jul; 287(6385):101-5. PubMed ID: 6407697
    [No Abstract]   [Full Text] [Related]  

  • 58. Short-course chemotherapy for extrapulmonary tuberculosis. Nine years' experience.
    Dutt AK; Moers D; Stead WW
    Ann Intern Med; 1986 Jan; 104(1):7-12. PubMed ID: 3940507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hong Kong Tuberculosis Treatment Services/British Medical Research Council study of short-course regimens of streptomycin, isoniazid and pyrazinamide: latest results.
    Girling DJ
    Tubercle; 1975 Jun; 56(2):165-6. PubMed ID: 1181689
    [No Abstract]   [Full Text] [Related]  

  • 60. Hong Kong tuberculosis treatment services/British Medical Research Council Study of 6- and 9-month regimens of daily and intermittent streptomycin, isoniazid and pyrazinamide for pulmonary tuberculosis.
    Allan WG
    Bull Int Union Tuberc; 1976; 51(1):91-3. PubMed ID: 1030317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.